Innoveren Scientific Inc - IVRN STOCK NEWS

Welcome to our dedicated page for Innoveren Scientific news (Ticker: IVRN), a resource for investors and traders seeking the latest updates and insights on Innoveren Scientific stock.

INNOVEREN SCIENTIFIC INC (symbol: IVRN) is a life science and biotech incubator company headquartered in Tampa, Florida. The company focuses on advancing new technologies in regenerative medicine, specifically for chronic lung diseases like chronic obstructive pulmonary disease (COPD). INNOVEREN submitted a premarket filing to the FDA for its SkinDiscTM Lite product, which utilizes autologous platelet-rich plasma to aid in wound healing. The company is also developing BreatheEasy, a medical device for COPD patients. INNOVEREN aims to improve patient lives by investing in innovative technologies with short timelines and low costs.

03/06/2024 08:00 AM

News

Innoveren Scientific Announces 510(k) Submission for SkinDisc(TM) Lite

Rhea-AI Summary

Innoveren Scientific Inc. submits its first commercial product, SkinDiscTM Lite, for FDA approval, utilizing autologous platelet-rich plasma for wound healing. The company aims to advance its regenerative medicine-based pipeline with future submissions, including SkinDiscTM Ultra and BreatheEasy.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

110.61%

Innoveren Scientific Divests Device & Receives Capital Infusion

Rhea-AI Summary

Innoveren Scientific Inc. completes divestiture of a medical device used in spinal surgeries, generating approximately $869,000 in net proceeds. The purchase price includes a three percent royalty stream on product commercialization. The capital infusion will be used for corporate rebranding, accelerating the acquisition pipeline, and attracting additional investment.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

59.83%

FAQ

What is the current stock price of Innoveren Scientific (IVRN)?

The current stock price of Innoveren Scientific (IVRN) is $0.000001 as of February 10, 2025.

What is the market cap of Innoveren Scientific (IVRN)?

The market cap of Innoveren Scientific (IVRN) is approximately 23.3K.

What is INNOVEREN SCIENTIFIC INC focused on?

INNOVEREN is focused on advancing new technologies in regenerative medicine for chronic lung diseases, particularly COPD.

Where is the headquarters of INNOVEREN SCIENTIFIC INC located?

The company is headquartered in Tampa, Florida.

What product did INNOVEREN submit to the FDA?

INNOVEREN submitted a premarket filing for its SkinDiscTM Lite product, utilizing autologous platelet-rich plasma for wound healing.

What is BreatheEasy?

BreatheEasy is a medical device being developed by INNOVEREN to help COPD patients.

What is the ultimate goal of INNOVEREN SCIENTIFIC INC?

The company aims to improve patient lives by investing in innovative technologies with short timelines and low costs.

What types of diseases does INNOVEREN focus on?

INNOVEREN focuses on chronic lung diseases such as COPD, chronic bronchitis, and emphysema.

What is the focus of INNOVEREN's product SkinDiscTM Lite?

SkinDiscTM Lite provides a protein-rich cellular matrix for structural support and cellular attachment during wound healing.

Why is the use of autologous platelet-rich plasma important in SkinDiscTM Lite?

The use of PRP in SkinDiscTM Lite helps mitigate potential rejection of the product, as the plasma is derived from the patient's own body.

What milestone did INNOVEREN recently achieve?

The company submitted a 510(k) premarket filing for SkinDiscTM Lite to the FDA, marking a significant milestone in its medical technology advancements.